📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Integration of Pharmacometrics and Pharmacoeconomics to Quantify the Value of Improved Forgiveness to Nonadherence: A Case Study of Novel Xanthine Oxidase Inhibitors for Gout. (2019)

First Author: Hill-McManus D

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/cpt.1454

PubMed Identifier: 30993686

Publication URI: http://europepmc.org/abstract/MED/30993686

Type: Journal Article/Review

Volume: 106

Parent Publication: Clinical pharmacology and therapeutics

Issue: 3

ISSN: 0009-9236